WuXi Biologics (Cayman) Inc. Stock OTC Markets
Equities
WXXWY
US98260N1081
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.846 USD | -1.19% | -10.74% | -61.80% |
Sales 2024 * | 18.14B 2.5B 3.42B | Sales 2025 * | 21.59B 2.98B 4.07B | Capitalization | 43.14B 5.96B 8.13B |
---|---|---|---|---|---|
Net income 2024 * | 3.85B 532M 726M | Net income 2025 * | 4.87B 672M 917M | EV / Sales 2024 * | 1.98 x |
Net cash position 2024 * | 7.25B 1B 1.37B | Net cash position 2025 * | 8.19B 1.13B 1.54B | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
11.6
x | P/E ratio 2025 * |
9.09
x | Employees | 12,740 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.48% |
Latest transcript on WuXi Biologics (Cayman) Inc.
1 day | -1.19% | ||
1 week | -10.74% | ||
Current month | -16.30% | ||
1 month | -16.30% | ||
3 months | -40.47% | ||
6 months | -74.32% | ||
Current year | -61.80% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 11-05-31 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 21-08-22 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 23-05-05 |
William Keller
BRD | Director/Board Member | 75 | 17-05-16 |
Ge Li
CHM | Chairman | 56 | 10-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 2.846 | -1.19% | 88,813 |
24-05-29 | 2.88 | -2.24% | 113,802 |
24-05-28 | 2.946 | -6.77% | 257,427 |
24-05-24 | 3.16 | -0.88% | 42,127 |
24-05-23 | 3.188 | -3.74% | 110,185 |
Delayed Quote OTC Markets, May 30, 2024 at 03:54 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.92% | 114B | |
+10.48% | 105B | |
-3.03% | 21.73B | |
-6.45% | 23.83B | |
-10.60% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- 2269 Stock
- WXXWY Stock